(Q40327817)

reason for preferred rank

19 September 2017

title

The metabolic consequences of adrenergic blockade: A review (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

6 June 2022

The metabolic consequences of adrenergic blockade: a reveiw (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238094

6 June 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238094

6 June 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

6 June 2022

author name string

J. L. Day

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238094

6 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238094

6 June 2022

publication date

1 August 1975

1 reference

full work available at URL

19 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0026049575900906?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

https://api.elsevier.com/content/article/PII:0026049575900906?httpAccept=text/plain

6 June 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

6 June 2022

1 reference

19 September 2017

volume

24

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

987-996

1 reference

Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia

19 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

6 June 2022

Diabetic angiography

2

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Role of Insulin in Endogenous Hypertriglyceridemia*

6 June 2022

3

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Arterial lipid metabolism in relation, to blood glucose and plasma insulin in rats with streptozotocin-induced diabetes.

6 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari

6 June 2022

5

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

A study of the adrenotropic receptors

6 June 2022

6

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Differentiation of Receptor Systems activated by Sympathomimetic Amines

6 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Selective blockade of adrenoceptive beta receptors in the heart

6 June 2022

10

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The effect of epinephrine on immunoreactive insulin levels in man

6 June 2022

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Epinephrine: selective inhibition of the acute insulin response to glucose

6 June 2022

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Studies of secretin-stimulated insulin responses in man.

6 June 2022

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of Epinephrine on Insulin Release in Man induced by Secretin

6 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Adrenergic Modulation of Basal Insulin Secretion in Man

6 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Metabolic response to simultaneous infusion of epinephrine and Propranolol in obese adolescents

6 June 2022

16

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Oral and intravenous D-ribose and plasma insulin in healthy humans: effects of route of administration and of epinephrine and propranolol.

6 June 2022

18

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Autonomic control of insulin secretion and the treatment of heart failure

6 June 2022

19

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man

6 June 2022

21

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Beta Adrenergic Stimulation of Insulin Release in Man

6 June 2022

22

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

A receptor mechanism for the inhibition of insulin release by epinephrine in man

6 June 2022

23

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of alpha-adrenergic blockade on insulin secretion in man

6 June 2022

24

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of blockade of the alpha-adrenergic receptors on insulin response to glucose infusion in prediabetic subjects

6 June 2022

0 references

Serum insulin concentration after alpha-adrenergic blockade and secretin in diabetics

26

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Influence of adrenergic receptor stimulation on glucose metabolism during starvation in man: effects on circulating levels of insulin growth hormone and free fatty acids

6 June 2022

27

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The effect of the -receptor blockade (propranolol) on the endocrine and exocrine pancreatic function in man after the administration of intestinal hormones (secretion and cholecystokinin-pancreozymin)

6 June 2022

28

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of adrenergic blocking agents on insulin response to glucose infusion in man

6 June 2022

29

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

EFFECTS OF β-SYMPATHETIC BLOCKADE ON NON-ESTERIFIED-FATTY-ACID AND CARBOHYDRATE METABOLISM AT REST AND DURING EXERCISE

6 June 2022

30

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effects of propranolol on blood sugar, insulin and free fatty acids

6 June 2022

31

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Glucagon?An essential hormone

6 June 2022

33

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Hypoglycaemia precipitated by propranolol

6 June 2022

34

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Propranolol and hypoglycaemia.

6 June 2022

35

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The influence of physical stress and exercise on growth hormone and insulin secretion in man

6 June 2022

37

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Adrenergic receptor control mechanism for growth hormone secretion

6 June 2022

38

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Adrenergic control of hormone secretion

6 June 2022

39

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia

6 June 2022

40

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Receptor mechanisms in the hyperglycaemic response to adrenaline in man

6 June 2022

41

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Interaction of amines and aminergic blocking agents with blood glucose regulation. II. Alpha-adrenergic blockade

6 June 2022

42

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

On sympathetic regulation of carbohydrate metabolism in the liver

6 June 2022

43

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

PHOSPHORYLASE ACTIVITY IN RAT LIVER AND SKELETAL MUSCLE AFTER CATECHOLAMINES

6 June 2022

44

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of β-Adrenergic Blockade on Resting and Stimulated Fat Mobilization

6 June 2022

46

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The effect of beta-adrenergic blocking agents on serum lipids

6 June 2022

47

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Propranolol and hypertriglyceridemia

6 June 2022

48

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Changes in glucagon level associated with anxiety or stress.

6 June 2022

51

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Stimulation of Glucagon Secretion by Epinephrine in Man

6 June 2022

53

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Adrenergic Modulation of Pancreatic Glucagon Secretion in Man

6 June 2022

54

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Role of alpha-adrenergic blockade on alanine-induced hyperglucagonemia.

6 June 2022

56

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor

6 June 2022

57

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effect of acetyl choline on the secretion of glucagon and insulin from the isolated, perfused canine pancreas

6 June 2022

58

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor

6 June 2022

59

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Insulin Secretion in Adrenergic Insufficiency in Man

6 June 2022

60

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Cyclic AMP and adrenergic receptor control of rat liver glycogen metabolism

6 June 2022

61

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Interactions of catecholamines and adrenergic blocking agents at receptor sites mediating glycogenolysis in the rat

6 June 2022

63

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.

6 June 2022

67

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Stimulation of glucagon and insulin secretion by acetylcholine infused intrapancreatically.

6 June 2022

69

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Gluconeogenesis in epinephrine-induced hyperglycemia

6 June 2022

70

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction

6 June 2022

72

1 reference

https://api.crossref.org/works/10.1016/0026-0495(75)90090-6

6 June 2022

Identifiers

1 reference

19 September 2017

1 reference